188 related articles for article (PubMed ID: 37074930)
1. Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.
Barbieri F; Bajetto A; Dellacasagrande I; Solari A; Würth R; Fernandez V; Rancati S; Ceresa D; Appolloni I; De Luca G; Dono M; Nozza P; Schiapparelli P; Gambaro M; Fiaschi P; Gaggero G; Costanzo N; Thellung S; Malatesta P; Pagano A; Zona G; De Pietri Tonelli D; Florio T
Neuro Oncol; 2023 Oct; 25(10):1775-1787. PubMed ID: 37074930
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
5. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
Koch C; Fischer NC; Puchert M; Engele J
BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
[TBL] [Abstract][Full Text] [Related]
7. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
[TBL] [Abstract][Full Text] [Related]
8. CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury.
Mousessian AS; Nunes da Silva CP; Oba-Shinjo SM; Kolias AG; Paiva WS; Nagahashi Marie SK
World Neurosurg; 2021 Mar; 147():e16-e24. PubMed ID: 33189916
[TBL] [Abstract][Full Text] [Related]
9. Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature.
Würth R; Barbieri F; Bajetto A; Pattarozzi A; Gatti M; Porcile C; Zona G; Ravetti JL; Spaziante R; Florio T
J Neuroimmunol; 2011 May; 234(1-2):115-23. PubMed ID: 21316111
[TBL] [Abstract][Full Text] [Related]
10. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
[TBL] [Abstract][Full Text] [Related]
11. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
Daniel SK; Seo YD; Pillarisetty VG
Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
16. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.
San-Miguel T; Pinto S; Navarro L; Callaghan RC; Monteagudo C; López-Ginés C; Cerdá-Nicolás M; Gil-Benso R
Pathol Oncol Res; 2015 Sep; 21(4):1191-9. PubMed ID: 26037167
[TBL] [Abstract][Full Text] [Related]
18. CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Chen Q; Zhang M; Li Y; Xu D; Wang Y; Song A; Zhu B; Huang Y; Zheng JC
Stem Cells; 2015 Aug; 33(8):2574-85. PubMed ID: 25833331
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
20. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
